These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1601729)

  • 1. Complications associated with the use of iohexol for myelography of the cervical vertebral column in dogs: 66 cases (1988-1990).
    Lewis DD; Hosgood G
    J Am Vet Med Assoc; 1992 May; 200(9):1381-4. PubMed ID: 1601729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of anesthetic regimen on the frequency of seizures after cervical myelography in the dog.
    Gray PR; Indrieri RJ; Lippert AC
    J Am Vet Med Assoc; 1987 Mar; 190(5):527-30. PubMed ID: 3558089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of and risk factors for seizures after myelography performed with iohexol in dogs: 503 cases (2002-2004).
    da Costa RC; Parent JM; Dobson H
    J Am Vet Med Assoc; 2011 May; 238(10):1296-300. PubMed ID: 21568775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of pentobarbital sodium to reduce seizures in dogs after cervical myelography with metrizamide.
    Gray PR; Indrieri RJ; Lowrie CT
    J Am Vet Med Assoc; 1987 Jun; 190(11):1422-4. PubMed ID: 3610751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of postmetrizamide myelographic seizures in dogs, using 5% dextrose solution.
    Tamas PM; Walker MA; Paddleford RR; Tinkel SR
    J Am Vet Med Assoc; 1986 Apr; 188(7):710-2. PubMed ID: 3700226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of intravenous administration of dextrose or lactated Ringer's solution on seizure development in dogs after cervical myelography with metrizamide.
    Gray PR; Lowrie CT; Wetmore LA
    Am J Vet Res; 1987 Nov; 48(11):1600-2. PubMed ID: 3434904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors associated with development of seizures after use of iohexol for myelography in dogs: 182 cases (1998).
    Barone G; Ziemer LS; Shofer FS; Steinberg SA
    J Am Vet Med Assoc; 2002 May; 220(10):1499-502. PubMed ID: 12018377
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical evaluation of metrizamide as a myelographic agent in the dog.
    Stowater JL; Kneller SK
    J Am Vet Med Assoc; 1979 Jul; 175(2):191-5. PubMed ID: 500441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of seizures associated with iopamidol or iomeprol myelography in dogs with intervertebral disk disease: 161 cases (2000-2002).
    Lexmaulova L; Zatloukal J; Proks P; Dvorak M; Srnec R; Rauser P; Kecova H; Necas A
    J Vet Emerg Crit Care (San Antonio); 2009 Dec; 19(6):611-6. PubMed ID: 20017767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of seizures associated with the use of acepromazine in dogs undergoing myelography.
    Drynan EA; Gray P; Raisis AL
    J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):262-6. PubMed ID: 22487256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective clinical trial comparing metrizamide and iohexol for equine myelography.
    Widmer WR; Blevins WE; Jakovljevic S; Levy M; Teclaw RF; Han CM; Hurd CD
    Vet Radiol Ultrasound; 1998; 39(2):106-9. PubMed ID: 9548136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of metrizamide and iohexol for cisternal myelographic examination of dogs.
    Puglisi TA; Green RW; Hall CL; Read WK; Green RA; Tangner CH; Mann FA; Hobson HP
    Am J Vet Res; 1986 Aug; 47(8):1863-9. PubMed ID: 3530068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal injection of Iohexol for routine myelography and CT myelography in 1,000 cases.
    Wang YS; Jiang YH; Hou ZY
    Chin Med J (Engl); 1990 Jun; 103(6):497-502. PubMed ID: 2209203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myelography with Omnipaque (Iohexol) using basic radiographic facilities: the main adverse effects.
    Ndosi BN; Ndosi NK; Kazema RR
    Cent Afr J Med; 1996 Jul; 42(7):192-5. PubMed ID: 8936782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of nonionic contrast agents iohexol and iotrolan for cisternal myelography in dogs.
    van Bree H; Van Rijssen B; Van Ham L
    Am J Vet Res; 1991 Jun; 52(6):926-33. PubMed ID: 1883098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Observation of a secondary compressive lesion after treatment of caudal cervical spondylomyelopathy in a dog.
    Wilson ER; Aron DN; Roberts RE
    J Am Vet Med Assoc; 1994 Nov; 205(9):1297-9. PubMed ID: 7698941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morphologic and morphometric magnetic resonance imaging features of Doberman Pinschers with and without clinical signs of cervical spondylomyelopathy.
    da Costa RC; Parent JM; Partlow G; Dobson H; Holmberg DL; Lamarre J
    Am J Vet Res; 2006 Sep; 67(9):1601-12. PubMed ID: 16948609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of dogs admitted for treatment of cervical intervertebral disk disease: 105 cases (1972-1982).
    Dallman MJ; Palettas P; Bojrab MJ
    J Am Vet Med Assoc; 1992 Jun; 200(12):2009-11. PubMed ID: 1639716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asystole associated with iohexol myelography in a dog.
    Carroll GL; Keene BW; Forrest LJ
    Vet Radiol Ultrasound; 1997; 38(4):284-7. PubMed ID: 9262685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hypoparathyroidism in dogs: a retrospective study of 17 cases.
    Russell NJ; Bond KA; Robertson ID; Parry BW; Irwin PJ
    Aust Vet J; 2006 Aug; 84(8):285-90. PubMed ID: 16911229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.